Report Categories
View AllRecent Articles
View All
Gilead Sciences Inc GILD FDA Grants Priority Review for Investigational OnceDaily HIV SingleTablet Regimen BICLEN
SVAQW Silicon quarterly earnings figures remain undisclosed as investors await full official operational updates
How FTAI FTAIM insider activity aligns with performance FTAI posts 152 negative EPS surprise falling short of estimates
RPID Rapid posts wider Q4 2025 loss than projected with shares gaining modestly on positive investor sentiment